We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Draft Guidance Addresses Public Participation in Open FDA Hearings
New Draft Guidance Addresses Public Participation in Open FDA Hearings
February 14, 2005
The FDA published a new draft guidance Feb. 14 that provides recommendations on how the public, including industry representatives, may participate in open public hearing sessions conducted as part of advisory committee meetings.